|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KD4DL-1-E |
Lysine-specific Demethylase 4D-like (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3550 |
0.42 |
Binding ≤ 10μM |
Z101879-1-O |
Leptomonas Seymouri (cluster #1 Of 1), Other |
Other |
400 |
0.50 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
6310 |
0.40 |
Functional ≤ 10μM
|
Z50466-5-O |
Trypanosoma Cruzi (cluster #5 Of 8), Other |
Other |
210 |
0.52 |
Functional ≤ 10μM
|
Z80002-2-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
800 |
0.47 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
7 |
0.63 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
1650 |
0.45 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
9960 |
0.39 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
1130 |
0.46 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4210 |
0.42 |
Functional ≤ 10μM
|
Z80980-1-O |
HOS (Osteosarcoma Cells) (cluster #1 Of 2), Other |
Other |
1400 |
0.46 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
1800 |
0.45 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
250 |
0.51 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
2100 |
0.44 |
ADME/T ≤ 10μM
|
Z80156-4-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 4), Other |
Other |
270 |
0.51 |
ADME/T ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
700 |
0.48 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.95 |
8.03 |
-10.63 |
0 |
3 |
0 |
43 |
242.274 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 75 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TYSY-3-E |
Thymidylate Synthase (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
7000 |
0.80 |
Binding ≤ 10μM
|
Z103205-4-O |
A431 (cluster #4 Of 4), Other |
Other |
18 |
1.20 |
Functional ≤ 10μM
|
Z103419-1-O |
UACC-812 (cluster #1 Of 2), Other |
Other |
3100 |
0.86 |
Functional ≤ 10μM
|
Z50425-14-O |
Plasmodium Falciparum (cluster #14 Of 22), Other |
Other |
7943 |
0.79 |
Functional ≤ 10μM
|
Z80035-6-O |
B16 (Melanoma Cells) (cluster #6 Of 7), Other |
Other |
8730 |
0.79 |
Functional ≤ 10μM
|
Z80054-2-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #2 Of 4), Other |
Other |
1500 |
0.91 |
Functional ≤ 10μM
|
Z80064-6-O |
CCRF-CEM (T-cell Leukemia) (cluster #6 Of 9), Other |
Other |
5000 |
0.82 |
Functional ≤ 10μM
|
Z80088-4-O |
CHO (Ovarian Cells) (cluster #4 Of 4), Other |
Other |
5000 |
0.82 |
Functional ≤ 10μM
|
Z80101-1-O |
COLO 320DM (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.93 |
Functional ≤ 10μM |
Z80120-3-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other |
Other |
6000 |
0.81 |
Functional ≤ 10μM |
Z80125-6-O |
DU-145 (Prostate Carcinoma) (cluster #6 Of 9), Other |
Other |
4800 |
0.83 |
Functional ≤ 10μM
|
Z80136-3-O |
FM3A (Breast Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
180 |
1.05 |
Functional ≤ 10μM
|
Z80156-6-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #6 Of 12), Other |
Other |
9500 |
0.78 |
Functional ≤ 10μM
|
Z80164-4-O |
HT-1080 (Fibrosarcoma Cells) (cluster #4 Of 6), Other |
Other |
9450 |
0.78 |
Functional ≤ 10μM
|
Z80166-8-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #8 Of 12), Other |
Other |
7300 |
0.80 |
Functional ≤ 10μM
|
Z80186-7-O |
K562 (Erythroleukemia Cells) (cluster #7 Of 11), Other |
Other |
2400 |
0.87 |
Functional ≤ 10μM
|
Z80192-2-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #2 Of 4), Other |
Other |
8320 |
0.79 |
Functional ≤ 10μM
|
Z80193-8-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #8 Of 12), Other |
Other |
970 |
0.94 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
9600 |
0.78 |
Functional ≤ 10μM
|
Z80268-1-O |
MKN-28 (Gastric Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2500 |
0.87 |
Functional ≤ 10μM |
Z80269-3-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #3 Of 3), Other |
Other |
3000 |
0.86 |
Functional ≤ 10μM |
Z80347-2-O |
NUGC-3 (Gastric Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
4400 |
0.83 |
Functional ≤ 10μM |
Z80362-5-O |
P388 (Lymphoma Cells) (cluster #5 Of 8), Other |
Other |
609 |
0.97 |
Functional ≤ 10μM |
Z80390-6-O |
PC-3 (Prostate Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
16 |
1.21 |
Functional ≤ 10μM
|
Z80485-4-O |
SK-MEL-28 (Melanoma Cells) (cluster #4 Of 6), Other |
Other |
4500 |
0.83 |
Functional ≤ 10μM
|
Z80490-4-O |
SK-MES-1 (cluster #4 Of 4), Other |
Other |
310 |
1.01 |
Functional ≤ 10μM
|
Z80525-2-O |
SW48 (cluster #2 Of 2), Other |
Other |
5700 |
0.82 |
Functional ≤ 10μM |
Z80526-3-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #3 Of 6), Other |
Other |
8100 |
0.79 |
Functional ≤ 10μM
|
Z80532-5-O |
T-24 (Bladder Carcinoma Cells) (cluster #5 Of 6), Other |
Other |
4100 |
0.84 |
Functional ≤ 10μM
|
Z80583-6-O |
Vero (Kidney Cells) (cluster #6 Of 7), Other |
Other |
6810 |
0.80 |
Functional ≤ 10μM
|
Z80641-1-O |
791T Cell Line (cluster #1 Of 1), Other |
Other |
5500 |
0.82 |
Functional ≤ 10μM
|
Z80653-2-O |
9L (Glioma Cells) (cluster #2 Of 2), Other |
Other |
1000 |
0.93 |
Functional ≤ 10μM
|
Z80682-9-O |
A549 (Lung Carcinoma Cells) (cluster #9 Of 11), Other |
Other |
9200 |
0.78 |
Functional ≤ 10μM
|
Z80686-1-O |
AZ-521 Cell Line (cluster #1 Of 1), Other |
Other |
3900 |
0.84 |
Functional ≤ 10μM |
Z80712-5-O |
T47D (Breast Carcinoma Cells) (cluster #5 Of 7), Other |
Other |
600 |
0.97 |
Functional ≤ 10μM
|
Z80724-1-O |
C170 Cell Line (cluster #1 Of 1), Other |
Other |
2000 |
0.89 |
Functional ≤ 10μM
|
Z80742-2-O |
C6 (Glioma Cells) (cluster #2 Of 3), Other |
Other |
6100 |
0.81 |
Functional ≤ 10μM
|
Z80874-5-O |
CEM (T-cell Leukemia) (cluster #5 Of 7), Other |
Other |
9230 |
0.78 |
Functional ≤ 10μM
|
Z80928-7-O |
HCT-116 (Colon Carcinoma Cells) (cluster #7 Of 9), Other |
Other |
8510 |
0.79 |
Functional ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 8), Other |
Other |
9200 |
0.78 |
Functional ≤ 10μM
|
Z81024-6-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #6 Of 8), Other |
Other |
8500 |
0.79 |
Functional ≤ 10μM |
Z81034-5-O |
A2780 (Ovarian Carcinoma Cells) (cluster #5 Of 10), Other |
Other |
7210 |
0.80 |
Functional ≤ 10μM
|
Z81041-1-O |
Prostatic Carcinoma Cells (cluster #1 Of 2), Other |
Other |
6400 |
0.81 |
Functional ≤ 10μM
|
Z81043-2-O |
N592 (cluster #2 Of 2), Other |
Other |
5400 |
0.82 |
Functional ≤ 10μM
|
Z81048-1-O |
TSU (Prostatic Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3600 |
0.85 |
Functional ≤ 10μM
|
Z81115-6-O |
KB (Squamous Cell Carcinoma) (cluster #6 Of 6), Other |
Other |
4460 |
0.83 |
Functional ≤ 10μM
|
Z81121-1-O |
KKLS Cell Line (cluster #1 Of 1), Other |
Other |
6200 |
0.81 |
Functional ≤ 10μM |
Z81170-4-O |
LNCaP (Prostate Carcinoma) (cluster #4 Of 5), Other |
Other |
4900 |
0.83 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
9700 |
0.78 |
Functional ≤ 10μM
|
Z81252-9-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #9 Of 11), Other |
Other |
9600 |
0.78 |
Functional ≤ 10μM
|
Z81330-1-O |
SNU- (cluster #1 Of 1), Other |
Other |
2700 |
0.87 |
Functional ≤ 10μM |
Z81331-3-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #3 Of 6), Other |
Other |
9000 |
0.78 |
Functional ≤ 10μM
|
Z81335-3-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #3 Of 5), Other |
Other |
9710 |
0.78 |
Functional ≤ 10μM
|
Z80156-3-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #3 Of 4), Other |
Other |
160 |
1.06 |
ADME/T ≤ 10μM
|
Z80192-2-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
7940 |
0.79 |
ADME/T ≤ 10μM
|
Z80193-4-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #4 Of 4), Other |
Other |
560 |
0.97 |
ADME/T ≤ 10μM
|
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
200 |
1.04 |
ADME/T ≤ 10μM
|
Z80901-2-O |
HaCaT (Keratinocytes) (cluster #2 Of 2), Other |
Other |
400 |
1.00 |
ADME/T ≤ 10μM
|
Z80928-2-O |
HCT-116 (Colon Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
2040 |
0.89 |
ADME/T ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 3), Other |
Other |
570 |
0.97 |
ADME/T ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
6610 |
0.81 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.59 |
-1.23 |
-13.33 |
2 |
4 |
0 |
66 |
130.078 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
-0.13 |
-4 |
-48.58 |
1 |
4 |
-1 |
69 |
129.07 |
0 |
↓
|
Mid
Mid (pH 6-8)
|
-0.13 |
-3.14 |
-32.57 |
1 |
4 |
-1 |
69 |
129.07 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.95 |
1.79 |
-8.21 |
0 |
3 |
0 |
43 |
242.274 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 41 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.38 |
4.79 |
-13.99 |
2 |
3 |
0 |
58 |
226.231 |
0 |
↓
|
Ref
Reference (pH 7)
|
3.48 |
2.85 |
-10.96 |
3 |
3 |
0 |
61 |
226.231 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
3.48 |
3.96 |
-43.55 |
2 |
3 |
-1 |
64 |
225.223 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80901-2-O |
HaCaT (Keratinocytes) (cluster #2 Of 2), Other |
Other |
10000 |
0.41 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.09 |
2.93 |
-41.99 |
2 |
4 |
-1 |
76 |
226.211 |
0 |
↓
|
|
|
Analogs
-
6117388
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
1500 |
0.45 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.78 |
5.46 |
-13.74 |
2 |
3 |
0 |
58 |
240.258 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
3.88 |
4.61 |
-44.23 |
2 |
3 |
-1 |
64 |
239.25 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
3.78 |
6.45 |
-63.24 |
1 |
3 |
-1 |
60 |
239.25 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
2100 |
0.47 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.75 |
1.06 |
-5.39 |
0 |
1 |
0 |
17 |
263.123 |
0 |
↓
|
|
|
Analogs
-
6523722
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80901-2-O |
HaCaT (Keratinocytes) (cluster #2 Of 2), Other |
Other |
600 |
0.48 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.90 |
4.12 |
-48.03 |
1 |
4 |
-1 |
65 |
240.238 |
0 |
↓
|
Mid
Mid (pH 6-8)
|
1.90 |
3.34 |
-13.74 |
2 |
4 |
0 |
62 |
241.246 |
0 |
↓
|
Mid
Mid (pH 6-8)
|
1.90 |
4.32 |
-64.35 |
1 |
4 |
-1 |
65 |
240.238 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80035-5-O |
B16 (Melanoma Cells) (cluster #5 Of 7), Other |
Other |
269 |
0.40 |
Functional ≤ 10μM
|
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
218 |
0.41 |
Functional ≤ 10μM
|
Z80193-1-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #1 Of 12), Other |
Other |
415 |
0.39 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
185 |
0.41 |
Functional ≤ 10μM
|
Z80224-12-O |
MCF7 (Breast Carcinoma Cells) (cluster #12 Of 14), Other |
Other |
19 |
0.47 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
47 |
0.45 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
338 |
0.39 |
Functional ≤ 10μM
|
Z80461-1-O |
SCL-1 (cluster #1 Of 1), Other |
Other |
383 |
0.39 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
31 |
0.46 |
Functional ≤ 10μM
|
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
320 |
0.40 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
213 |
0.41 |
Functional ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
47 |
0.45 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
192 |
0.41 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
470 |
0.39 |
Functional ≤ 10μM
|
Z81252-7-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #7 Of 11), Other |
Other |
428 |
0.39 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.13 |
1.81 |
-10.68 |
1 |
5 |
0 |
65 |
316.353 |
7 |
↓
|
|
|
Analogs
-
5724366
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 14 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.13 |
2.17 |
-9.54 |
2 |
4 |
0 |
75 |
190.154 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.32 |
Functional ≤ 10μM
|
Z80901-2-O |
HaCaT (Keratinocytes) (cluster #2 Of 2), Other |
Other |
3200 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.85 |
2.24 |
-14.96 |
0 |
4 |
0 |
40 |
321.376 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 17 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.66 |
4.18 |
-20.39 |
6 |
8 |
0 |
156 |
504.45 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100751-1-O |
PMNL (Polymorphonuclear Leukocytes) (cluster #1 Of 2), Other |
Other |
8000 |
0.26 |
Functional ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
2600 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.30 |
7.88 |
-57.17 |
1 |
7 |
-1 |
105 |
373.381 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 21 More
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.40 |
3.54 |
-8.75 |
1 |
3 |
0 |
54 |
174.155 |
0 |
↓
|
Hi
High (pH 8-9.5)
|
1.40 |
4.54 |
-46.63 |
0 |
3 |
-1 |
57 |
173.147 |
0 |
↓
|
|
|
Analogs
-
3977873
-
-
3977874
-
-
3977875
-
-
4245621
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CASP3-1-E |
Caspase-3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.20 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
810 |
0.20 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.25 |
Functional ≤ 10μM
|
Z100733-1-O |
CT26 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
200 |
0.22 |
Functional ≤ 10μM
|
Z100752-1-O |
Renca (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2900 |
0.18 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
3920 |
0.18 |
Functional ≤ 10μM
|
Z103204-2-O |
A427 (cluster #2 Of 4), Other |
Other |
130 |
0.23 |
Functional ≤ 10μM
|
Z103413-1-O |
SW948 (cluster #1 Of 1), Other |
Other |
1300 |
0.20 |
Functional ≤ 10μM
|
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
5012 |
0.18 |
Functional ≤ 10μM
|
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
990 |
0.20 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
530 |
0.21 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2150 |
0.19 |
Functional ≤ 10μM
|
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
360 |
0.21 |
Functional ≤ 10μM |
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
9000 |
0.17 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
1200 |
0.20 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
100 |
0.23 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
350 |
0.22 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
380 |
0.21 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
5160 |
0.18 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
970 |
0.20 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
750 |
0.20 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
6600 |
0.17 |
Functional ≤ 10μM
|
Z80179-1-O |
J82 (Bladder Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM |
Z80186-9-O |
K562 (Erythroleukemia Cells) (cluster #9 Of 11), Other |
Other |
522 |
0.21 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
567 |
0.21 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
834 |
0.20 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2300 |
0.19 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
878 |
0.20 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
600 |
0.21 |
Functional ≤ 10μM
|
Z80284-3-O |
MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other |
Other |
65 |
0.24 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM |
Z80288-1-O |
MOVP-3 (cluster #1 Of 1), Other |
Other |
7550 |
0.17 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
1250 |
0.20 |
Functional ≤ 10μM
|
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
1500 |
0.19 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
50 |
0.24 |
Functional ≤ 10μM
|
Z80390-2-O |
PC-3 (Prostate Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
7800 |
0.17 |
Functional ≤ 10μM
|
Z80435-1-O |
RT-112 (cluster #1 Of 1), Other |
Other |
220 |
0.22 |
Functional ≤ 10μM
|
Z80436-1-O |
RT-4 (cluster #1 Of 1), Other |
Other |
1330 |
0.20 |
Functional ≤ 10μM
|
Z80473-1-O |
SISO (cluster #1 Of 2), Other |
Other |
150 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
300 |
0.22 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
5720 |
0.17 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
850 |
0.20 |
Functional ≤ 10μM
|
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
2500 |
0.19 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
275 |
0.22 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z80546-1-O |
TERT-RPE1 (Retinal Pigmented Epithelial Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z80548-4-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #4 Of 5), Other |
Other |
2160 |
0.19 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
3480 |
0.18 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
140 |
0.23 |
Functional ≤ 10μM
|
Z80604-1-O |
YAPC (cluster #1 Of 2), Other |
Other |
1320 |
0.20 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
9980 |
0.17 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
3667 |
0.18 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
740 |
0.20 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
591 |
0.21 |
Functional ≤ 10μM
|
Z80866-1-O |
GLC4 Cell Line (cluster #1 Of 1), Other |
Other |
820 |
0.20 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1590 |
0.19 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1192 |
0.20 |
Functional ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
550 |
0.21 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
9500 |
0.17 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
4900 |
0.18 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
90 |
0.23 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
500 |
0.21 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
3250 |
0.18 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
985 |
0.20 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
160 |
0.23 |
Functional ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
800 |
0.20 |
Functional ≤ 10μM
|
Z81126-1-O |
KYSE-150 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81128-1-O |
KYSE-520 Cell Line (cluster #1 Of 1), Other |
Other |
410 |
0.21 |
Functional ≤ 10μM
|
Z81130-1-O |
KYSE-70 Cell Line (cluster #1 Of 1), Other |
Other |
790 |
0.20 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
180 |
0.22 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
577 |
0.21 |
Functional ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
8930 |
0.17 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
700 |
0.21 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
240 |
0.22 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
80 |
0.24 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
900 |
0.20 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.22 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
3930 |
0.18 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.70 |
-7.49 |
-18.52 |
3 |
13 |
0 |
160 |
588.562 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 22 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
2100 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Mid
Mid (pH 6-8)
|
1.59 |
5.79 |
-89.07 |
1 |
7 |
-2 |
127 |
342.303 |
2 |
↓
|
Lo
Low (pH 4.5-6)
|
1.01 |
4.25 |
-18.97 |
2 |
7 |
0 |
118 |
344.319 |
2 |
↓
|
|
|
Analogs
-
517415
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
1700 |
0.24 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.97 |
-3.1 |
-64.4 |
4 |
10 |
-1 |
173 |
467.406 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KCNA3-2-E |
Voltage-gated Potassium Channel Subunit Kv1.3 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
5800 |
0.28 |
Binding ≤ 10μM
|
KCNN4-1-E |
Intermediate Conductance Calcium-activated Potassium Channel Protein 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2100 |
0.31 |
Binding ≤ 10μM
|
Z80901-1-O |
HaCaT (Keratinocytes) (cluster #1 Of 2), Other |
Other |
8400 |
0.27 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.48 |
9.48 |
-13.52 |
0 |
4 |
0 |
54 |
363.438 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 17 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80901-2-O |
HaCaT (Keratinocytes) (cluster #2 Of 2), Other |
Other |
2800 |
0.52 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.27 |
1.35 |
-14.8 |
2 |
5 |
0 |
80 |
208.169 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.02 |
4.75 |
-10.47 |
1 |
7 |
0 |
101 |
314.363 |
5 |
↓
|
Mid
Mid (pH 6-8)
|
3.02 |
4.81 |
-35.55 |
0 |
7 |
-1 |
103 |
313.355 |
5 |
↓
|
|